| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |